The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gleeson Christopher M since 2006.
The trader's CIK number is 1134540.
At the time of the last reporting, Gleeson Christopher M was the President & CEO of Genmark Diagnostics, Inc.. (stock ticker symbol GNMK).
Also see all insider trading activities at Genmark Diagnostics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | VMSI | 0 | $0 | 0 | $0 | 527,409 | $46,269,706 |
| 2007 | VMSI | 0 | $0 | 0 | $0 | 20,000 | $5,188,540 |
| 2006 | VMSI | 0 | $0 | 80,000 | $3,602,400 | 100,598 | $897,208 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | GNMK | 0 | $0 | 50,000 | $588,370 | 0 | $0 |
| 2012 | GNMK | 60,000 | $252,000 | 0 | $0 | 0 | $0 |
| 2011 | GNMK | 15,000 | $60,000 | 0 | $0 | 0 | $0 |
| 2010 | GNMK | 1,333,333 | $7,999,998 | 0 | $0 | 0 | $0 |
1. Ventana Medical Systems Inc (VMSI)
2. Genmark Diagnostics, Inc. (GNMK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-02-07 | VMSI | Option Ex | 516,305 | 89.40 | 46,157,667 |
| 2008-01-28 | VMSI | Option Ex | 11,104 | 10.09 | 112,039 |
| 2007-02-13 | VMSI | Option Ex | 20,000 | 259.43 | 5,188,540 |
| 2006-12-15 | VMSI | Option Ex | 20,598 | 8.84 | 182,168 |
| 2006-04-28 | VMSI | Option Ex | 80,000 | 8.94 | 715,040 |
| 2006-04-28 | VMSI | Sale | 80,000 | 45.03 | 3,602,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-03-20 | GNMK | Sale | 16,000 | 11.56 | 184,960 |
| 2013-03-18 | GNMK | Sale | 17,000 | 11.80 | 200,600 |
| 2013-03-15 | GNMK | Sale | 17,000 | 11.93 | 202,810 |
| 2012-06-26 | GNMK | Buy | 60,000 | 4.20 | 252,000 |
| 2011-03-16 | GNMK | Buy | 15,000 | 4.00 | 60,000 |
| 2010-06-03 | GNMK | Buy | 1,333,333 | 6.00 | 7,999,998 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gleeson Christopher M (President & CEO of Genmark Diagnostics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.